General
Preferred name
ERGOTAMINE
Synonyms
Migril ()
Gynergen ()
Cafergot ()
Femergin ()
Lingraine ()
Ergotamine D-tartrate ()
NSC-95090 ()
Ergotamina ()
ERGOTAMINE TARTRATE ()
Medihaler Ergotamine ()
NSC-41869 ()
Ergomar ()
Ergotamine bitartrate ()
Ergostat ()
Gotamine tartrate ()
Ergotamini tartras ()
Wigrettes ()
P&D ID
PD009841
CAS
113-15-5
1080650-16-3
379-79-3
Tags
available
biased GPCR ligand
drug
Approved by
FDA
First approval
1948
Drug indication
Headache
Analgesic (specific in migraine)
Drug Status
approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Ergotamine is an ergot derived alkaloid. (GtoPdb)
Compound Sets
21
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
ReFrame library
External IDs
49
Properties
(calculated by RDKit )
Molecular Weight
581.26
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
3
Rotatable Bonds
4
Ring Count
8
Aromatic Ring Count
3
cLogP
1.99
TPSA
118.21
Fraction CSP3
0.42
Chiral centers
6.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Member status
virtual
MOA
Serotonin, dopamine and epinephrine receptor agonist
Adrenergic Receptor antagonist
Indication
migraine headache
Target
ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2
Therapeutic Class
Analgesics
Source data